These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 22284137)

  • 1. The Skindex instruments to measure the effects of skin disease on quality of life.
    Chren MM
    Dermatol Clin; 2012 Apr; 30(2):231-6, xiii. PubMed ID: 22284137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Spanish version of Skindex-29.
    Jones-Caballero M; Peñas PF; García-Díez A; Badía X; Chren MM
    Int J Dermatol; 2000 Dec; 39(12):907-12. PubMed ID: 11168659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translation and Validation of the Serbian Version of the Skindex-29 Instrument for Measuring Impact of Skin Disease on Quality of Life.
    Milutinović JD; Krstić N; Janković SM
    Acta Dermatovenerol Croat; 2017 Jul; 25(2):120-127. PubMed ID: 28871926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of an Egyptian Arabic Version of Skindex-16 and Quality of Life Measurement in Egyptian Patients with Skin Disease.
    Essa N; Awad S; Nashaat M
    Int J Behav Med; 2018 Apr; 25(2):243-251. PubMed ID: 28748378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further evidence of the validity and reliability of the Skindex-29: an Italian study on 2,242 dermatological outpatients.
    Abeni D; Picardi A; Pasquini P; Melchi CF; Chren MM
    Dermatology; 2002; 204(1):43-9. PubMed ID: 11834849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convergent and discriminant validity of a generic and a disease-specific instrument to measure quality of life in patients with skin disease.
    Chren MM; Lasek RJ; Quinn LM; Covinsky KE
    J Invest Dermatol; 1997 Jan; 108(1):103-7. PubMed ID: 8980297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases.
    Chren MM; Lasek RJ; Sahay AP; Sands LP
    J Cutan Med Surg; 2001; 5(2):105-10. PubMed ID: 11443481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Japanese version of Skindex-16: a brief quality-of-life measure for patients with skin diseases.
    Higaki Y; Kawamoto K; Kamo T; Horikawa N; Kawashima M; Chren MM
    J Dermatol; 2002 Nov; 29(11):693-8. PubMed ID: 12484430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Turkish version of Skindex-29.
    Aksu AE; Urer MS; Sabuncu I; Saracoglu ZN; Chren MM
    Int J Dermatol; 2007 Apr; 46(4):350-5. PubMed ID: 17442071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and psychometric validation of the Chinese version of Skindex-29 and Skindex-16.
    He Z; Lu C; Chren MM; Zhang Z; Li Y; Ni X; Buchtel V HA; Ryan PF; Li GZ
    Health Qual Life Outcomes; 2014 Dec; 12():190. PubMed ID: 25539748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Field performance of the Skindex-17 quality of life questionnaire: a comparison with the Skindex-29 in a large sample of dermatological outpatients.
    Sampogna F; Spagnoli A; Di Pietro C; Pagliarello C; Paradisi A; Tabolli S; Abeni D
    J Invest Dermatol; 2013 Jan; 133(1):104-9. PubMed ID: 22832497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical meaning in skin-specific quality of life instruments: a comparison of the Dermatology Life Quality Index and Skindex banding systems.
    Rogers A; DeLong LK; Chen SC
    Dermatol Clin; 2012 Apr; 30(2):333-42, x. PubMed ID: 22284147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arabic version of Skindex-16: translation and cultural adaptation, with assessment of reliability and validity.
    AlGhamdi KM; AlShammari SA
    Int J Dermatol; 2007 Mar; 46(3):247-52. PubMed ID: 17343578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptation of a Runyankore version of Skindex-16 for oral administration in Mbarara, Uganda.
    Chua SL; Maurer T; Chren MM
    Int J Dermatol; 2011 Oct; 50(10):1249-54. PubMed ID: 21950290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases.
    Chren MM; Lasek RJ; Flocke SA; Zyzanski SJ
    Arch Dermatol; 1997 Nov; 133(11):1433-40. PubMed ID: 9371029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical review of generic and dermatology-specific health-related quality of life instruments.
    Both H; Essink-Bot ML; Busschbach J; Nijsten T
    J Invest Dermatol; 2007 Dec; 127(12):2726-39. PubMed ID: 17989733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of Skindex-Teen, a quality-of-life instrument for adolescents with skin disease.
    Smidt AC; Lai JS; Cella D; Patel S; Mancini AJ; Chamlin SL
    Arch Dermatol; 2010 Aug; 146(8):865-9. PubMed ID: 20713817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychometric characteristics of DLQI-BRA and Skindex-16 to measure the impact of dermatological diseases on quality of life in Brazilian patients.
    Meneguin S; de Souza Matos TD; Pollo CF; Garuzi M; Miot HA; de Oliveira C
    PLoS One; 2021; 16(8):e0254882. PubMed ID: 34388159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Categorization of Skindex-29 scores using mixture analysis.
    Nijsten T; Sampogna F; Abeni D
    Dermatology; 2009; 218(2):151-4. PubMed ID: 19060458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness.
    Chren MM; Lasek RJ; Quinn LM; Mostow EN; Zyzanski SJ
    J Invest Dermatol; 1996 Nov; 107(5):707-13. PubMed ID: 8875954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.